日本における入院しダビガトランまたはワルファリン投与を開始した非弁膜症性心房細動患者の入院期間

基本情報

NCT ID

NCT02631057

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

4,313

治験依頼者名

Boehringer Ingelheim

概要

The primary objective of this study is to compare the Length of Stay from treatment of oral anticoagulant initiation to hospital discharge of patients hospitalized and subsequently treated with dabigatran or warfarin for non-valvular atrial fibrillation in a real-world Japanese clinical practice. The secondary objective of the study is to compare LoS of patients hospitalized with 1) acute ischemic stroke, and 2) due to non-valvular atrial fibrillation. Other objectives are (1) to compare the in-hospital direct and indirect-related costs between dabigatran and warfarin, and (2) to compare the rates of patients directly discharged at home after the index hospitalization between dabigatran and warfarin.

対象疾患

介入

依頼者（Sponsor）

実施施設 (2)